BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 30935201)

  • 1. DCPIB, an Inhibitor of Volume-Regulated Anion Channels, Distinctly Modulates K2P Channels.
    Lv J; Liang Y; Zhang S; Lan Q; Xu Z; Wu X; Kang L; Ren J; Cao Y; Wu T; Lin KL; Yung KKL; Cao X; Pang J; Zhou P
    ACS Chem Neurosci; 2019 Jun; 10(6):2786-2793. PubMed ID: 30935201
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The inhibitor of volume-regulated anion channels DCPIB activates TREK potassium channels in cultured astrocytes.
    Minieri L; Pivonkova H; Caprini M; Harantova L; Anderova M; Ferroni S
    Br J Pharmacol; 2013 Mar; 168(5):1240-54. PubMed ID: 23072356
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protein and Chemical Determinants of BL-1249 Action and Selectivity for K
    Pope L; Arrigoni C; Lou H; Bryant C; Gallardo-Godoy A; Renslo AR; Minor DL
    ACS Chem Neurosci; 2018 Dec; 9(12):3153-3165. PubMed ID: 30089357
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heterodimerization within the TREK channel subfamily produces a diverse family of highly regulated potassium channels.
    Levitz J; Royal P; Comoglio Y; Wdziekonski B; Schaub S; Clemens DM; Isacoff EY; Sandoz G
    Proc Natl Acad Sci U S A; 2016 Apr; 113(15):4194-9. PubMed ID: 27035963
    [TBL] [Abstract][Full Text] [Related]  

  • 5. β-COP Suppresses the Surface Expression of the TREK2.
    Kim SS; Park J; Kim E; Hwang EM; Park JY
    Cells; 2023 May; 12(11):. PubMed ID: 37296621
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuronal microRNAs modulate TREK two-pore domain K
    Paschou M; Maier L; Papazafiri P; Selescu T; Dedos SG; Babes A; Doxakis E
    RNA Biol; 2020 May; 17(5):651-662. PubMed ID: 31994436
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of leak potassium channels in pain signaling.
    Li XY; Toyoda H
    Brain Res Bull; 2015 Oct; 119(Pt A):73-9. PubMed ID: 26321392
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DCPIB, a potent volume-regulated anion channel antagonist, attenuates microglia-mediated inflammatory response and neuronal injury following focal cerebral ischemia.
    Han Q; Liu S; Li Z; Hu F; Zhang Q; Zhou M; Chen J; Lei T; Zhang H
    Brain Res; 2014 Jan; 1542():176-85. PubMed ID: 24189520
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DCPIB, the proposed selective blocker of volume-regulated anion channels, inhibits several glutamate transport pathways in glial cells.
    Bowens NH; Dohare P; Kuo YH; Mongin AA
    Mol Pharmacol; 2013 Jan; 83(1):22-32. PubMed ID: 23012257
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of gastric H+,K+-ATPase by 4-(2-butyl-6,7-dichloro-2-cyclopentylindan-1-on-5-yl)oxybutyric acid (DCPIB), an inhibitor of volume-regulated anion channel.
    Fujii T; Takahashi Y; Takeshima H; Saitoh C; Shimizu T; Takeguchi N; Sakai H
    Eur J Pharmacol; 2015 Oct; 765():34-41. PubMed ID: 26277321
    [TBL] [Abstract][Full Text] [Related]  

  • 11. GI-530159, a novel, selective, mechanosensitive two-pore-domain potassium (K
    Loucif AJC; Saintot PP; Liu J; Antonio BM; Zellmer SG; Yoger K; Veale EL; Wilbrey A; Omoto K; Cao L; Gutteridge A; Castle NA; Stevens EB; Mathie A
    Br J Pharmacol; 2018 Jun; 175(12):2272-2283. PubMed ID: 29150838
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Two-pore Domain Potassium Channels in Astrocytes.
    Ryoo K; Park JY
    Exp Neurobiol; 2016 Oct; 25(5):222-232. PubMed ID: 27790056
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The LRRC8 volume-regulated anion channel inhibitor, DCPIB, inhibits mitochondrial respiration independently of the channel.
    Afzal A; Figueroa EE; Kharade SV; Bittman K; Matlock BK; Flaherty DK; Denton JS
    Physiol Rep; 2019 Dec; 7(23):e14303. PubMed ID: 31814333
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Negative Influence by the Force: Mechanically Induced Hyperpolarization via K
    Lengyel M; Enyedi P; Czirják G
    Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445768
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Two-pore domain potassium channels: potential therapeutic targets for the treatment of pain.
    Mathie A; Veale EL
    Pflugers Arch; 2015 May; 467(5):931-43. PubMed ID: 25420526
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel DCPIB analogs as dual inhibitors of VRAC/TREK1 channels reduced cGAS-STING mediated interferon responses.
    Zhi Y; Liu J; Kuang P; Zhang X; Xu Z; Chen Y; Lin X; Wu X; Zhou P; Chen J
    Biochem Pharmacol; 2022 May; 199():114988. PubMed ID: 35278418
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The potassium channels TASK2 and TREK1 regulate functional differentiation of murine skeletal muscle cells.
    Afzali AM; Ruck T; Herrmann AM; Iking J; Sommer C; Kleinschnitz C; Preuβe C; Stenzel W; Budde T; Wiendl H; Bittner S; Meuth SG
    Am J Physiol Cell Physiol; 2016 Oct; 311(4):C583-C595. PubMed ID: 27488672
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular Pharmacology of K
    Decher N; Rinné S; Bedoya M; Gonzalez W; Kiper AK
    Cell Physiol Biochem; 2021 Mar; 55(S3):87-107. PubMed ID: 33667333
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Two-pore-domain potassium channels and molecular mechanisms underlying migraine].
    Royal P; Ávalos Prado P; Wdziekonski B; Sandoz G
    Biol Aujourdhui; 2019; 213(1-2):51-57. PubMed ID: 31274103
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DCPIB is a novel selective blocker of I(Cl,swell) and prevents swelling-induced shortening of guinea-pig atrial action potential duration.
    Decher N; Lang HJ; Nilius B; Brüggemann A; Busch AE; Steinmeyer K
    Br J Pharmacol; 2001 Dec; 134(7):1467-79. PubMed ID: 11724753
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.